Does RALTITREXED Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with RALTITREXED. This represents 1.4% of all adverse event reports for RALTITREXED.
6
Reports of Malignant neoplasm progression with RALTITREXED
1.4%
of all RALTITREXED reports
5
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From RALTITREXED?
Of the 6 reports, 5 (83.3%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RALTITREXED. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RALTITREXED Cause?
Diarrhoea (82)
Myelosuppression (77)
Anaemia (49)
Neutropenia (48)
Vomiting (46)
Nausea (45)
Disease progression (40)
Fatigue (38)
Asthenia (33)
Hepatic function abnormal (26)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which RALTITREXED Alternatives Have Lower Malignant neoplasm progression Risk?
RALTITREXED vs RAMELTEON
RALTITREXED vs RAMIPRIL
RALTITREXED vs RAMUCIRUMAB
RALTITREXED vs RANEXA
RALTITREXED vs RANIBIZUMAB